TR201720510A2 - Orally disintegrating tablet formulations of ivabradine - Google Patents

Orally disintegrating tablet formulations of ivabradine Download PDF

Info

Publication number
TR201720510A2
TR201720510A2 TR2017/20510A TR201720510A TR201720510A2 TR 201720510 A2 TR201720510 A2 TR 201720510A2 TR 2017/20510 A TR2017/20510 A TR 2017/20510A TR 201720510 A TR201720510 A TR 201720510A TR 201720510 A2 TR201720510 A2 TR 201720510A2
Authority
TR
Turkey
Prior art keywords
ivabradine
orally disintegrating
disintegrating tablet
tablet formulations
pharmaceutically acceptable
Prior art date
Application number
TR2017/20510A
Other languages
English (en)
Inventor
Güner Di̇cle
Palantöken Arzu
Türkyilmaz Ali̇
Original Assignee
Sanovel Ilac Sanayi Ve Ticaret Anonim Sirketi
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sanovel Ilac Sanayi Ve Ticaret Anonim Sirketi filed Critical Sanovel Ilac Sanayi Ve Ticaret Anonim Sirketi
Priority to TR2017/20510A priority Critical patent/TR201720510A2/tr
Publication of TR201720510A2 publication Critical patent/TR201720510A2/tr

Links

Landscapes

  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

The present invention relates to an orally disintegrating pharmaceutical formulation comprising ivabradine or a pharmaceutically acceptable salt, solvate or polymorph thereof and one or more pharmaceutically acceptable excipients.
TR2017/20510A 2017-12-15 2017-12-15 Orally disintegrating tablet formulations of ivabradine TR201720510A2 (tr)

Priority Applications (1)

Application Number Priority Date Filing Date Title
TR2017/20510A TR201720510A2 (tr) 2017-12-15 2017-12-15 Orally disintegrating tablet formulations of ivabradine

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
TR2017/20510A TR201720510A2 (tr) 2017-12-15 2017-12-15 Orally disintegrating tablet formulations of ivabradine

Publications (1)

Publication Number Publication Date
TR201720510A2 true TR201720510A2 (tr) 2019-07-22

Family

ID=67900887

Family Applications (1)

Application Number Title Priority Date Filing Date
TR2017/20510A TR201720510A2 (tr) 2017-12-15 2017-12-15 Orally disintegrating tablet formulations of ivabradine

Country Status (1)

Country Link
TR (1) TR201720510A2 (tr)

Similar Documents

Publication Publication Date Title
IL283134A (en) Alcohol-resistant drug formulations
EA201892395A1 (ru) Лекарственные составы ингибитора lsd1
PH12019501076A1 (en) Pharmaceutical formulations
PH12019501639A1 (en) Jaki selective inhibitors
EA201792592A1 (ru) Фармацевтические препараты, содержащие тенофовир и эмтрицитабин
EA201792591A1 (ru) Фармацевтические препараты
CU24486B1 (es) Dispersión sólida amorfa que comprende taxano, tabletas comprendiendo la misma y método para prepararla
PH12017502249A1 (en) Tofacitinib orally disintegrating tablets
MX387731B (es) Composiciones farmacéuticas orales de mesalazina.
PH12020550815A1 (en) Delayed release deferiprone tablets and methods of using the same
WO2015125152A3 (en) Pharmaceutical compositions of asenapine
EA201890944A1 (ru) Фармацевтические композиции нилотиниба гидрохлорида
EA202090913A1 (ru) Композиция таблеток с модифицированным высвобождением, содержащая мирабегрон
WO2019151964A3 (en) Orally disintegrating formulations of saxagliptin
TR201310724A2 (tr) Linagliptinin farmasotik formulasyonları.
EP3965739C0 (en) DOSAGE FORMULATIONS OF OLEYL PHOSPHOCHOLINE TABLETS
MX2021005681A (es) Combinacion de un inhibidor de mcl-1 y midostaurina, usos y composiciones farmaceuticas de la misma.
TR201720510A2 (tr) Orally disintegrating tablet formulations of ivabradine
WO2019209217A3 (en) Modified release formulations of flurbiprofen
EA201991007A1 (ru) Твердые фармацевтические композиции на основе гидрохлорида луразидона для перорального применения
EA201691422A1 (ru) Перорально распадающиеся таблетированные составы мемантина
JOP20200005B1 (ar) تركيبات صيدلية
WO2019221684A3 (en) The bilayer tablet formulation of fesoterodine
JOP20200104B1 (ar) مركبات مثبطة لـ btk
WO2020018053A3 (en) The tablet comprising dasatinib